跳至主要内容
临床试验/NCT00705744
NCT00705744已完成3 期

Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Femina.

Sanofi1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2008年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Sanofi
入组人数
26
试验地点
1
主要终点
The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale

研究概览

简要总结

To prove the absence of photo irritation and photo sensitivity potential of the product Dermacyd Femina.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Phototype Skin II and III;
  • Integral skin test in the region;

排除标准

  • Lactation or gestation;
  • Use of Anti-inflammatory and/or immuno-suppression drugs 15 days before the selection;
  • Diseases which can cause immunity decrease, such as HIV, diabetes;
  • Use of drug photosensitizer;
  • History of sensitivity or irritation for topic products;
  • Active cutaneous disease which can change the study results;
  • History or photodermatosis active;
  • Family or personal antecedent of cutaneous photoinduced neoplasias;
  • Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and keratoses actinium;
  • Intense solar exposure in the study area;
  • Use of new drugs or cosmetics during the study;
  • The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

研究组 & 干预措施

I

Experimental

干预措施: Lactic acid (Dermacyd Femina) (Drug)

结局指标

主要结局

The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale

时间窗: 5 weeks

The sensibility will be evaluated according to the skin type.

时间窗: 5 weeks

次要结局

未报告次要终点

研究者

发起方
Sanofi
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验